150 related articles for article (PubMed ID: 8366522)
1. The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis.
Loomes LM; Kerr MA; Senior BW
J Med Microbiol; 1993 Sep; 39(3):225-32. PubMed ID: 8366522
[TBL] [Abstract][Full Text] [Related]
2. Proteus mirabilis strains of diverse type have IgA protease activity.
Senior BW; Albrechtsen M; Kerr MA
J Med Microbiol; 1987 Sep; 24(2):175-80. PubMed ID: 3309325
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of IgG and IgA in vitro and in vivo by the urinary tract pathogen Proteus mirabilis.
Kerr MA; Loomes LM; Senior BW
Adv Exp Med Biol; 1995; 371A():609-11. PubMed ID: 8526000
[No Abstract] [Full Text] [Related]
4. The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract.
Senior BW; Loomes LM; Kerr MA
J Med Microbiol; 1991 Oct; 35(4):203-7. PubMed ID: 1941989
[TBL] [Abstract][Full Text] [Related]
5. A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes.
Loomes LM; Senior BW; Kerr MA
Infect Immun; 1990 Jun; 58(6):1979-85. PubMed ID: 2111288
[TBL] [Abstract][Full Text] [Related]
6. Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients.
Loomes LM; Senior BW; Kerr MA
Infect Immun; 1992 Jun; 60(6):2267-73. PubMed ID: 1587593
[TBL] [Abstract][Full Text] [Related]
7. The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract.
Adegbola RA; Old DC; Senior BW
J Med Microbiol; 1983 Nov; 16(4):427-31. PubMed ID: 6139485
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of Proteus mirabilis urinary tract infection.
Coker C; Poore CA; Li X; Mobley HL
Microbes Infect; 2000 Oct; 2(12):1497-505. PubMed ID: 11099936
[TBL] [Abstract][Full Text] [Related]
9. Determination immunogenic property of truncated MrpH.FliC as a vaccine candidate against urinary tract infections caused by Proteus mirabilis.
Bameri Z; Asadi Karam MR; Habibi M; Ehsani P; Bouzari S
Microb Pathog; 2018 Jan; 114():99-106. PubMed ID: 29138084
[TBL] [Abstract][Full Text] [Related]
10. The special affinity of particular types of Proteus mirabilis for the urinary tract.
Senior BW
J Med Microbiol; 1979 Feb; 12(1):1-8. PubMed ID: 372530
[TBL] [Abstract][Full Text] [Related]
11. Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls.
Senior BW; Anderson GA; Morley KD; Kerr MA
J Infect; 1999 Mar; 38(2):99-106. PubMed ID: 10342649
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional consequences of cleavage of human secretory and human serum immunoglobulin A1 by proteinases from Proteus mirabilis and Neisseria meningitidis.
Almogren A; Senior BW; Loomes LM; Kerr MA
Infect Immun; 2003 Jun; 71(6):3349-56. PubMed ID: 12761118
[TBL] [Abstract][Full Text] [Related]
13. The ability of a Proteus mirabilis strain to invade the bloodstream is independent of its proticine production/proticine sensitivity type.
Senior BW
J Med Microbiol; 1997 May; 46(5):407-12. PubMed ID: 9152037
[TBL] [Abstract][Full Text] [Related]
14. New aspects of RpoE in uropathogenic Proteus mirabilis.
Liu MC; Kuo KT; Chien HF; Tsai YL; Liaw SJ
Infect Immun; 2015 Mar; 83(3):966-77. PubMed ID: 25547796
[TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced.
Berasain P; Carmona C; Frangione B; Dalton JP; Goñi F
Exp Parasitol; 2000 Feb; 94(2):99-110. PubMed ID: 10673346
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
Khan AU; Musharraf A
Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
[TBL] [Abstract][Full Text] [Related]
17. Effects of the administration of cholera toxin as a mucosal adjuvant on the immune and protective response induced by Proteus mirabilis MrpA fimbrial protein in the urinary tract.
Scavone P; Rial A; Umpierrez A; Chabalgoity A; Zunino P
Microbiol Immunol; 2009 Apr; 53(4):233-40. PubMed ID: 19714860
[TBL] [Abstract][Full Text] [Related]
18. Analysis of inflammatory cytokine expression in the urinary tract of BALB/c mice infected with Proteus (P.) mirabilis and enteroaggregative Escherichia (E.) coli (EAEC) strains.
Melendez-Avalos A; Sainz-Espuñes T; Castrillón-Rivera LE; Mendoza-Pérez F; Palma-Ramos A; Castañeda-Sánchez JI; Drago-Serrano EM
Folia Microbiol (Praha); 2020 Feb; 65(1):133-142. PubMed ID: 31104302
[TBL] [Abstract][Full Text] [Related]
19. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains.
Fusco A; Coretti L; Savio V; Buommino E; Lembo F; Donnarumma G
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212280
[TBL] [Abstract][Full Text] [Related]
20. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
Chen CY; Chen YH; Lu PL; Lin WR; Chen TC; Lin CY
J Microbiol Immunol Infect; 2012 Jun; 45(3):228-36. PubMed ID: 22572004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
